Aesculap Implant Systems established a warranty program for Plasmapore®XP-coated spinal interbody fusion devices.
In the instance of re-operation due to clinically-relevant delamination, or if impaction debris or a CT or MRI artifact caused by the device interferes with the visualization of adjacent anatomy, the warranty offers a device replacement.
This is the first facility risk-share agreement on a titanium-enhanced PEEK interbody in the spine industry to warrant against delamination of a surface enhancement and the ability to visualize an implant without artifact.
The announcement coincides with launch of the TSpace®XP interbody system, which is treated with the PlasmaporeXP surface enhancement.
Aesculap’s proprietary process applies a porous, osteoconductive and biocompatible titanium surface to each PlasmaporeXP implant on the top, bottom and lateral surfaces. Results from ovine study suggest that PlasmaporeXP-coated PEEK interbody implants have significantly greater pullout strength and bony ingrowth than uncoated implants at 12 and 24 weeks.
The use of surface technologies is expected to continue and evolve in the interbody segment.
Aesculap Implant Systems established a warranty program for Plasmapore®XP-coated spinal interbody fusion devices.
In the instance of re-operation due to clinically-relevant delamination, or if impaction debris or a CT or MRI artifact caused by the device interferes with the visualization of adjacent anatomy, the warranty offers a device...
Aesculap Implant Systems established a warranty program for Plasmapore®XP-coated spinal interbody fusion devices.
In the instance of re-operation due to clinically-relevant delamination, or if impaction debris or a CT or MRI artifact caused by the device interferes with the visualization of adjacent anatomy, the warranty offers a device replacement.
This is the first facility risk-share agreement on a titanium-enhanced PEEK interbody in the spine industry to warrant against delamination of a surface enhancement and the ability to visualize an implant without artifact.
The announcement coincides with launch of the TSpace®XP interbody system, which is treated with the PlasmaporeXP surface enhancement.
Aesculap’s proprietary process applies a porous, osteoconductive and biocompatible titanium surface to each PlasmaporeXP implant on the top, bottom and lateral surfaces. Results from ovine study suggest that PlasmaporeXP-coated PEEK interbody implants have significantly greater pullout strength and bony ingrowth than uncoated implants at 12 and 24 weeks.
The use of surface technologies is expected to continue and evolve in the interbody segment.
Copy to clipboard 
